Comments Sought on Opioid Policy Committee

Federal Register notice: FDA is seeking comments or suggestions on issues relevant to the agency’s newly established Opioid Policy Steering Committee. The agency wants feedback on how its authorities can or should be used to address the opioid crisis. It is interested in hearing about three key areas: What more can FDA do to ensure that the full range of available information, including about possible public health effects, is considered when making opioid-related regulatory decisions; what steps can FDA take with respect to dispensing and packaging (e.g., unit of use) to facilitate consistency of and promote appropriate prescribing practice; and should FDA require some form of mandatory education for health care professionals who prescribe opioid drug products, and if so, how should such a system be implemented? To view the notice, click here.